PBP1710 Anti-CTHRC1

PBP1710 Anti-CTHRC1
Product Description

Prestige Biopharma Limited

  • SG
  • 2018
    On CPHI since
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
Contract Service
Innovation cluster
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical

Prestige Biopharma Limited

  • SG
  • 2018
    On CPHI since
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
Contract Service
Innovation cluster
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical

More Products from Prestige Biopharma Limited (7)

  • PBP1510 (INN:ULENISTAMAB)

    Product PBP1510 (INN:ULENISTAMAB)

    Ulenistamab (PBP1510) is a First-in-Class antibody drug developed as a target of pancreatic adenocarcinoma up-regulated factor (PAUF) resulting in decreased autocrine and paracrine signaling implicated pancreatic cancer. It attenuates the tumorigenic potential of PAUF in both the pancreatic cancer cells an...
  • PAUF Pancreatic Cancer Diagnostic Kit

    Product PAUF Pancreatic Cancer Diagnostic Kit

    Pancreatic Adenocarcinoma Up-regulated Factor- PAUF is over-expressed in over 80% of pancreatic adenocarcinoma (PDAC). With our expertise in biosimilars and novel antibody drugs development and manufacturing, we are strongly positioned to tackle the unaddressed need of pancreatic cancer. Early detection an...
  • PBP1510 (Ulenistamab) Anti-PAUF Antibody for Pancreatic Cancer

    Product PBP1510 (Ulenistamab) Anti-PAUF Antibody for Pancreatic Cancer

    Ulenistamab (PBP1510) is a First-in-Class antibody drug developed as a target of pancreatic adenocarcinomaup-regulated factor (PAUF) resulting in decreased autocrine and paracrine signaling implicated pancreatic cancer.

    It attenuates the tumorigenic potential of PAUF in both the pancreatic cancer ce...

Prestige Biopharma Limited resources (1)